Investigating Key Molecular Descriptors Affecting Particle Size: A Predictive Exemplary Approach for Self-Emulsifying System.

The self-nano/microemulsifying drug delivery system is one of the well-established techniques for enhancing the solubility of poorly water-soluble drug molecules. The ratio of oil:surfactant:cosolvent plays a key role in globule size on dispersion into water, but there is very limited information on how a drug molecule affects the size. The rationale of this project was to illustrate the correlation between the particle size of nanoemulsion droplets and molecular descriptors of a drug. In the study, a self-nanoemulsifying preconcentrate containing drug with medium chain triglycerides (oil), dimethylacetamide (DMA, cosolvent), and Kolliphor EL (surfactant) was prepared for 40 drug molecules with diverse physicochemical properties. The self-nanoemulsifying preconcentrate was dispersed in water, and dynamic light scattering particle size was analyzed. A majority of drugs showed a significant increase in globule size compared to blank formulation, while few drugs showed a stark reduction in globule size. It is interesting to understand the attributes of molecules driving the self-emulsification and the diameter of nanoglobules. A systematic correlation of resultant particle size with 1D, 2D, and 3D molecular descriptors (overall more than 700 descriptors) was carried out for the data set using the PaDEL tool kit. The data compilation, curation, and analysis were performed using the SIMCA14 software. In the process of molecular descriptors screening, thereafter curation, 50 descriptors were selected using the genetic algorithm screening. The PLS-DA statistical method was employed for conversion of data into binomial systems. Final group of 5 descriptors: SpMiSpMin2_Bhe, RNCS, TDB9i, JG17, and ETA_Shape showed the correlation with particle size and classifying the drug molecules facilitating increase or decrease in particle size.

Development of a safe pediatric liquisolid self-nanoemulsifying system of triclabendazole for the treatment of fascioliasis.

Fascioliasis, a common parasitic infection observed in the pediatric patient population, is a leading cause of concern in countries with poor/unhealthy water resources. To treat this condition first line agent such as triclabendazole (TBZ) has been the choice therapy. However, there is a major hurdle in exploiting TBZ. Characterized with poor aqueous solubility (0.1 mg/L), its solubility has been the rate limiting factor, rendering requirement of large doses of TBZ. To address the same, the focus of the current study was to develop a self-nano emulsifying drug delivery system (TBZ-SNEDDS) for TBZ and developing dose customizable pediatric dispersible color-coded tablets. TBZ-SNEDDS were successfully formulated by using Kolliphor®EL, as a surfactant, a lipid phase of medium chain triglyceride and α-tocopherol in the ratio of (1:1), with dimethylacetamide (DMA) as a solvent. It was observed during in vitro release studies that there was a significant effect of fed conditions on the rate of TBZ release from the formulation. greater than 85 % TBZ was observed to release in fed conditions in comparison to fasted conditions. As currently TBZ is prescribed on a weight-based dosage regimen, it is imperative to develop a dose-customizable fast dissolving pediatric formulation. Hence, TBZ-SNEDDS could prove to be pivotal in helping countless children around the world in desperate conditions to get cheap yet effective therapy.